HydrALAZINE Hydrochloride
NDC 76282-312, HydrALAZINE Hydrochloride, tablet, from Exelan Pharmaceuticals Inc..
- Product NDC
- 76282-312
- Status
- Listed
- Labeler
- Exelan Pharmaceuticals Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090255
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/76282-312 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYDRALAZINE HYDROCHLORIDE100 mg/1
Pharmacologic classes
Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 76282-312-01 | 76282031201 | 100 TABLET in 1 BOTTLE (76282-312-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/811831f9-a844-463a-874d-fb8407659f0bNADAC price for package 76282031201
GET /v1/drugs/nadac/76282031201
Use it
Look up 76282-312 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/76282-312 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 76282-312. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.